Daniel W. Nebert - Pharma

Author Information

Daniel W. Nebert is affiliated with the Department of Environmental Health and Center for Environmental Genetics at the University of Cincinnati Medical Center, Cincinnati, OH, USA. His extensive work in the field of environmental health, genetics, and pharmacogenomics underscores his prominent role in scientific research. The affiliation information was sourced from PubMed, reflecting his current institutional association.

Research Contributions

Daniel W. Nebert has made significant contributions to various areas of genetic research, particularly in the fields of pharmacogenomics, gene family analysis, and genetic susceptibility to diseases. His recent work includes studies on the keratin gene family, the potential genetic susceptibility to COVID-19, and the PAX gene family's role in human diseases. His research has been pivotal in understanding the genetic basis of drug response, environmental influences on gene expression, and the evolution of gene families. Nebert's work has been widely recognized and cited in the scientific community, reflecting the impact of his research on advancing knowledge in genetics and personalized medicine.

Aliases

Daniel W. Nebert is also known by various aliases, including Daniel Nebert, D. W. Nebert, D. Nebert, Daniël Nebert, and D.w. Nebert. These variations are used interchangeably in different publications and databases.

Publication and Citation Metrics

Metric Value
H-index 112
Citation Count 52,038
Paper Count 561

Publications:

DOI: 10.1186/s40246-022-00379-y

Year: 2022

DOI: 10.1016/b978-0-12-812537-3.00016-0

Year: 2019

DOI: 10.1016/b978-0-12-812537-3.01002-7

Year: 2019

Partnered Content Networks

Relevant Topics